Logo.PNG
Veritas Pharma Announces Loan to Marapharm and Cancellation of Stock Options
July 27, 2018 18:51 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, July 27, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that effective June...
Logo.PNG
Veritas Pharma Signs IP Agreement with UK’s First Medicinal Cannabis Investment Fund
July 17, 2018 16:05 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, July 17, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that it has signed an...
Logo.PNG
Veritas Appoints Mr. Filios Theodorou as Its Agent for Cyprus and SEMEA Countries
June 25, 2018 03:15 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, June 25, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that Mr. Filios...
Logo.PNG
Veritas Pharma Provides Corporate Update on Q2 2018
May 31, 2018 03:10 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, May 31, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide a corporate update on its...
Logo.PNG
Veritas Pharma Provides Comment on Canadian Senate Recommendation for a One-Year Deferment Legalizing Cannabis
May 10, 2018 03:10 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, May 10, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) provides the following statement to the...
Logo.PNG
Veritas Pharma Establishes New Subsidiary in Puerto Rico, USA
May 07, 2018 03:10 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, May 07, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce the establishment of new...
Logo.PNG
Dr. Michael K. Pugsley Joins Veritas Pharma’s Advisory Board
April 18, 2018 03:50 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, April 18, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that Dr. Michael K....
Logo.PNG
Veritas Pharma Enters Into Share Purchase Agreement with 3 Carbon Extractions Inc.
April 16, 2018 07:30 ET | Veritas Pharma Inc.
3 Carbon is in the business of designing cannabis extraction facilities and utilizing its own proprietary extraction methods. VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Veritas...
Logo.PNG
Veritas Pharma Closes Private Placement
March 29, 2018 03:10 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, March 29, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announces the closing of a...
Logo.PNG
Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics
March 21, 2018 03:15 ET | Veritas Pharma Inc.
VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce the Company has...